Living Systematic Review of Therapeutic Options for Post Acute or Post COVID-19 Condition
Abstract
This review compiles the evidence on potential therapeutic options for post-COVID-19 conditions (PCC). Included are all the identified clinical forms, symptoms, and manifestations of PCC for which an intervention was assessed in at least one randomized controlled trial.
Subject
Collections
This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO
Related items
Showing items related by title, author, creator and subject.
-
Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review, 8 September 2020
(Washington, D.C., PAHO, 2020-09-11)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we have examined 40 therapeutic options. The Pan American Health Organization (PAHO) is ... -
Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews, 16 June 2020
(Washington, D.C., PAHO, 2020-06-16)Take home message thus far: • We examined 24 therapeutic options thus far; currently, there is no evidence of any important benefit from any therapeutic option (though remdesivir is revealing promise as one option based ... -
Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review, 11 August 2020
(Washington, D.C., PAHO, 2020-08-19)More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review, we examined 30 therapeutic options.
